UK medicines regulator needs more resources.Big money for biosimilars.Fixing liberalism.2024 scientific breakthroughs.The Economist: Best books of 2024.
November 24, 2025
- How Oura Expanded from Wellness to Healthcare
- Could Trump do for Branded Expensive Drugs What He Just Did for GLP-1s?
- Una crisis de salud oculta tras los desastres naturales: la proliferación de moho en los hogares
- The VBC Paradox: How Health Systems Can Balance Inpatient Revenue With Value-Based Care Goals
Headlines
